Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116266634 | 11626663 | 4 | F | 20150918 | 20160908 | 20151013 | 20160912 | PER | US-CELGENEUS-USA-2015102142 | CELGENE | 55.34 | YR | M | Y | 77.18000 | KG | 20160912 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116266634 | 11626663 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | U | UNKNOWN | 20785 | 100 | MG | CAPSULES | ||||||
| 116266634 | 11626663 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | UNKNOWN | 20785 | 100 | MG | CAPSULES | QD | |||||
| 116266634 | 11626663 | 3 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | 20 | MG | UNKNOWN | ||||||||
| 116266634 | 11626663 | 4 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 4 MILLIGRAM | 0 | 20 | MG | UNKNOWN | |||||||
| 116266634 | 11626663 | 5 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | 4 | MG | UNKNOWN | ||||||||
| 116266634 | 11626663 | 6 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | 40 | MG | UNKNOWN | ||||||||
| 116266634 | 11626663 | 7 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | 40 | MG | UNKNOWN | ||||||||
| 116266634 | 11626663 | 8 | C | CYTOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | 0 | 840 | MG | INJECTION | ||||||||
| 116266634 | 11626663 | 9 | C | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous drip | 0 | 20 | MG | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116266634 | 11626663 | 1 | Plasma cell myeloma |
| 116266634 | 11626663 | 3 | Product used for unknown indication |
| 116266634 | 11626663 | 8 | Product used for unknown indication |
| 116266634 | 11626663 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116266634 | 11626663 | HO |
| 116266634 | 11626663 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116266634 | 11626663 | Plasma cell myeloma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116266634 | 11626663 | 1 | 20150310 | 20150919 | 0 | |
| 116266634 | 11626663 | 2 | 20150903 | 20150919 | 0 | |
| 116266634 | 11626663 | 3 | 20100329 | 20100729 | 0 | |
| 116266634 | 11626663 | 4 | 20100803 | 20140109 | 0 | |
| 116266634 | 11626663 | 5 | 20140609 | 20140814 | 0 | |
| 116266634 | 11626663 | 6 | 20140821 | 20150226 | 0 | |
| 116266634 | 11626663 | 7 | 20150310 | 20150919 | 0 | |
| 116266634 | 11626663 | 8 | 20150310 | 20150919 | 0 | |
| 116266634 | 11626663 | 9 | 20150310 | 20150919 | 0 |